Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
preclinical-cro
Press Release
Nov 28, 2023
AmplifyBio Expands Its Vision: Launches Advanced Therapy Manufacturing Enablement Center in New Albany, Ohio
Read More
Press Release
Nov 7, 2023
AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
Read More
Press Release
May 25, 2023
AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety
Read More
Press Release
May 15, 2023
AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio
AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.
Read More
Press Release
Jan 12, 2023
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan
AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics
Read More
Press Release
Dec 1, 2022
AmplifyBio Chooses Blue Mountain to Achieve GMP Compliance and Advance Digital Strategy
A fast-growing, preclinical CRO, AmplifyBio is partnering with the SaaS leader in Good Manufacturing Practice (GMP) Solutions, Blue Mountain, to manage the maintenance, calibration and validation processes of their assets.
Read More
Press Release
Nov 10, 2022
AmplifyBio Announces Completion of Initiatives to Expand Vivarium Capacity
Preclinical CRO Capacity Expansion
Read More
Press Release
Jul 12, 2022
AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site
A preclinical CRO built for the future on a foundation of experience: amplify-bio.com
Read More
First
Prev
1
Next
Last
